Logo

American Heart Association

  2
  0


Final ID:

Biomarkers for Cardiotoxicity Monitoring: Do We Really Need Them, Or Are They Just Extra Baggage? (Pro)

  • Cardinale, Daniela  ( European Institute of Oncology , Milan , Italy )
  • Lopez-fernandez, Teresa  ( La Paz University Hospital, IdiPAZ , Madrid , Spain )
  • Scherrer-crosbie, Marielle  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    Daniela Cardinale: DO have relevant financial relationships ; Consultant:GILEAD:Active (exists now) ; Consultant:IPSEN:Past (completed) | Teresa Lopez-Fernandez: DO have relevant financial relationships ; Speaker:Philips:Past (completed) ; Advisor:myocardial solutions:Active (exists now) ; Advisor:beigene:Active (exists now) ; Advisor:astra zaneca:Active (exists now) ; Advisor:janssen:Active (exists now) ; Speaker:janssen:Past (completed) ; Speaker:pfizer:Past (completed) ; Speaker:daiichy-sankyo:Past (completed) ; Speaker:Bayer:Past (completed) ; Advisor:philips:Active (exists now) | Marielle Scherrer-Crosbie: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Great Debates in Cardio-Oncology: Let's Agree to Disagree

Saturday, 11/16/2024 , 03:15PM - 04:30PM

Cardiovascular Seminar

More abstracts from these authors:
The Year in Cardio-oncology

Lopez-fernandez Teresa, Zaha Vlad

Discussant: The SARAH Trial

Lopez-fernandez Teresa, Ky Bonnie

You have to be authorized to contact abstract author. Please, Login
Not Available